Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

397.52
BATS BZX Real-Time Price
As of 1:49pm ET
 +14.97 / +3.91%
Today’s Change
325.35
Today|||52-Week Range
452.96
+8.29%
Year-to-Date

Today’s Trading

Previous close382.55
Today’s open382.23
Day’s range382.23 - 401.08
Volume91,779
Average volume (3 months)943,582
Market cap$40.6B
Dividend yield--
Data as of 1:49pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+15.23%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+18.44%
P/E ratio51.7
Price/Sales8.79
Price/Book9.11

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-0.47-0.34%
BAXBaxter International...+0.14+0.27%
SHPGShire-0.05-0.03%
ZTSZoetis Inc-0.06-0.11%
Data as of 1:51pm ET, 03/29/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs